Search results
5 dni temu · Untreated behavioral health conditions can decrease a person’s quality of life and are associated with increased healthcare spending, 1, 2 and increased risk of adverse outcomes from co-morbidities, 3, 4 and premature mortality. 5, 6 Depression and anxiety disorders have well-documented links to increased cancer mortality and the risk of chronic obstructive pulmonary disease 7,8 as well as ...
3 dni temu · The association among negative life events, alexithymia, and depressive symptoms in a psychosomatic outpatient sample. Depression is a life-threatening mental health problem. Various factors have been demonstrated to be associated with depressive symptoms, including negative life events (NLEs) and alexithymia. A retrospective ...
4 dni temu · ORIGINAL RESEARCH article. Front. Public Health, 03 July 2024. ... For example, cognitive behavioral therapy, practical ... 47. Kim, D, Kwon, HJ, Ha, M, Lim, MH, and Kim, KM. Network analysis for the symptom of depression with Children's depression inventory in a large sample of school-aged children. J Affect Disord. (2021) 281:256–63. doi ...
4 dni temu · Over years, we discovered that viewing Wisdom through the lens of our operational definition better afforded TPs the ability to churn complex issues into understandable bits that facilitated practical problem-solving in therapeutic practice; reinforcing our stance that Wisdom is an ECTP.
5 dni temu · This section aims to improve the lives of people with Mood Disorders by rapidly communicating and publicizing key discoveries and fostering collaborative multidisciplinary research.
4 dni temu · Clinical data to support evidence-based treatment of MDD. Have greater competence related to. Individualizing treatment based on depression symptoms and patient preferences. Selecting treatments for residual or recurrent symptoms of MDD such as cognitive deficits, anhedonia, or sexual dysfunction.
3 dni temu · From Medscape Psychiatry. Achieving Remission in Depression: Raising the Standard of Care. Authors: Martin L. Korn, MD Faculty and Disclosures. Introduction. The first selective serotonin reuptake inhibitor (SSRI) to be introduced (fluoxetine) was a significant advance in the treatment of depressive disorders.
